Biotechnology startup

Enveda Biosciences

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

Funding reportedLast round: Series B

Biotechnology

What company datasets say Enveda Biosciences raised

Funding, as reported

Reported in all229.9Min the source's currency
Rounds7
Last roundSeries B
Last round dateJun 2024
Investors listed25

On 9 portfolio pages

Investors who name them

Each firm lists Enveda Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Enveda Biosciences in front of investors. Or tell us what we have wrong.